Research graph
References from Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid fever. Local targets link to admitted publications; unresolved targets remain external evidence.
The interplay between Salmonella and host: mechanisms and strategies for bacterial survival
10.1016/j.cellin.2025.100237 · 2025 · External reference
Salmonella infection: interplay between the bacteria and host immune system
10.1016/j.imlet.2017.07.006 · 2017 · External reference
What should we be recommending for the treatment of enteric fever?
10.1093/ofid/ofad179 · 2023 · External reference
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins
10.1002/14651858.cd010452.pub2 · 2022 · External reference
Assessing the global risk of typhoid outbreaks caused by extensively drug resistant Salmonella Typhi
10.1038/s41467-023-42353-9 · 2023 · External reference
Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins
10.1128/mbio.00105-18 · 2018 · External reference
Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes
10.1016/s0924-8579(02)00187-5 · 2002 · External reference
The pharmacokinetics of azithromycin in human serum and tissues
10.1093/jac/25.suppl_a.73 · 1990 · External reference
The pharmacokinetics of azithromycin and their clinical significance
10.1007/bf01975832 · 1991 · External reference
Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1500 milligrams, given over a 3- or 5-day period in healthy subjects
10.1128/aac.43.1.163 · 1999 · External reference
Response of extensively drug resistant Salmonella Typhi to treatment with meropenem and azithromycin, in Pakistan
10.1371/journal.pntd.0008682 · 2020 · External reference
Unresolved reference
External reference
Treatment of typhoid fever in the 21st century: promises and shortcomings
10.1111/j.1469-0691.2011.03552.x · 2011 · External reference
Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India
10.1093/jac/44.2.243 · 1999 · External reference
Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial
10.1128/aac.37.8.1572 · 1993 · External reference
Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella Typhi to treatment with trimethoprim-sulfamethoxazole
10.1093/clinids/4.2.551 · 1982 · External reference
Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever
10.1093/infdis/132.6.630 · 1975 · External reference
A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis
10.1136/bmj.b1865 · 2009 · External reference
The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam
10.1016/j.trstmh.2003.10.014 · 2004 · External reference
A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos
10.1016/j.trstmh.2004.08.007 · 2005 · External reference
The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy
10.1371/journal.pntd.0001163 · 2011 · External reference
Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1
10.1007/s101560070016 · 2000 · External reference
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance
10.1128/aac.43.6.1441 · 1999 · External reference
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever
10.1128/aac.00447-06 · 2007 · External reference
Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents
10.1086/382359 · 2004 · External reference
Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
10.1086/317450 · 2000 · External reference
Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections
10.1128/cmr.00002-15 · 2015 · External reference
A comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid fever: a randomised, open labelled study
10.7860/jcdr/2012/4702.2631 · 2012 · External reference
Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance
10.1371/journal.pntd.0007868 · 2019 · External reference
Open label comparative trial of mono versus dual antibiotic therapy for typhoid fever in adults
10.1371/journal.pntd.0006380 · 2018 · External reference
Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella
10.1128/mbio.03481-20 · 2021 · External reference
A race against time: reduced azithromycin susceptibility in Salmonella enterica serovar Typhi in Pakistan
10.1128/msphere.00215-20 · 2020 · External reference
Spontaneous emergence of azithromycin resistance in independent lineages of Salmonella Typhi in Northern India
10.1093/cid/ciaa1773 · 2021 · External reference
Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol
10.1093/infdis/158.4.742 · 1988 · External reference
XDR typhoid in Pakistan: a threat to global health security and a wake-up call for antimicrobial stewardship
10.1371/journal.pntd.0013067 · 2025 · External reference
Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci
10.1038/287440a0 · 1980 · External reference
Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization
10.1084/jem.20031319 · 2004 · External reference
A mouse model for the human pathogen Salmonella Typhi
10.1016/j.chom.2010.09.003 · 2010 · External reference
Unresolved reference
External reference
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis
10.1128/aac.01301-08 · 2009 · External reference
In vitro time-kill studies of trimethoprim/sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using cation-adjusted Mueller-Hinton broth and ISO-Sensitest broth
10.1128/aac.02167-21 · 2022 · External reference
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella Typhi within human monocyte-derived macrophages
10.1093/jac/26.5.689 · 1990 · External reference
The oral penems and carbapenems
10.1128/cmr.00042-24 · 2025 · External reference
Unresolved reference
2024 · External reference
Review of clinical experience with amdinocillin monotherapy and comparative studies
10.1016/0002-9343(83)90098-0 · 1983 · External reference
The combination of pivmecillinam and pivampicillin in the treatment of enteric fever
10.1007/bf01645219 · 1984 · External reference
Pivmecillinam for treatment of uncomplicated urinary tract infection: new efficacy analysis
10.1093/cid/ciaf280 · 2025 · External reference
New perspectives on antimicrobial agents: pivmecillinam
10.1128/aac.01824-24 · 2025 · External reference
Pharmacokinetic/pharmacodynamic determination of systemic MIC breakpoints for intermittent, extended, and continuous infusion dosage regimens of mecillinam
10.1128/spectrum.03441-22 · 2023 · External reference
Faropenem medoxomil
10.1345/aph.1g232 · 2008 · External reference
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations
10.1016/j.diagmicrobio.2022.115662 · 2022 · External reference
Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi
10.1093/jac/dkab326 · 2021 · External reference
Fosfomycin
10.1128/cmr.00068-15 · 2016 · External reference
Successful therapy of a multidrug-resistant extended-Spectrum β-lactamase-producing and fluoroquinolone-resistant Salmonella enterica subspecies enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin
10.1093/cid/cix652 · 2017 · External reference
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
10.1016/j.ijantimicag.2009.08.013 · 2009 · External reference
Pharmacodynamic evaluation of fosfomycin against Escherichia coli and Klebsiella spp. from urinary tract infections and the influence of pH on fosfomycin activities
10.1128/aac.02498-16 · 2017 · External reference
Intracellular activity of fosfomycin against two distinct enteropathogenic bacteria, Salmonella enterica and Listeria monocytogenes, alive inside host cells
10.1159/000069787 · 2003 · External reference
Inability of gentamicin and fosfomycin to eliminate intracellular Enterobacteriaceae
10.1093/jac/15.6.723 · 1985 · External reference
Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints
10.1093/jac/dkw226 · 2016 · External reference
Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol
10.12688/wellcomeopenres.16801.1 · 2021 · External reference
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo
10.1093/jac/46.6.973 · 2000 · External reference
In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?
10.1016/j.ijantimicag.2004.02.030 · 2004 · External reference
Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro
10.1128/aac.47.3.1151-1153.2003 · 2003 · External reference
Case of carbapenem-resistant Salmonella Typhi infection, Pakistan, 2022
10.3201/eid2911.230499 · 2023 · External reference
